Document Type


Publication Date

Spring 2019


Von Willebrand disease (VWD) is an autosomal inherited bleeding disorder in which a person is deficient, qualitatively and/or quantitatively, in an essential enzyme for the coagulation pathway, von Willebrand factor (VWF). Like many coagulation disorders, the disease is commonly classified into three subtypes that include varying degrees of severity. More specifically, type 1 is classified as a partial quantitative deficiency in the VWF, type 2 as a qualitative deficiency, and type 3 as a total deficiency. As to be expected, the importance of proper diagnosis and treatment of VWD in a clinical setting, either for surgical precautions or general care, is paramount. Hence the importance of many studies that have recently shown promise in the world of genetic and molecular testing. In the context of VWD, technology is becoming more universal and integrated in the world of diagnostics. This study aims to compare the available technology-based VWD genetic screening modalities to determine a viable methodology for an accurate diagnosis of VWD.


Faculty Adviser: Dr. Amorette Barber

Included in

Biology Commons



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.